SlideShare a Scribd company logo
Hepatitis C
Hepatitis C
• Identified in 1989
• Blood test became available in 1992
• Used to be known as “non-A, non-B” hepatitis
• Spread through blood-to- blood contact
• No vaccine available to prevent hepatitis C
Flaviviridaea
Hepaciviruses
Pestiviruses:
Classical swine
Fever virus
Bovine viral
Diarhoea virus
Flaviviruses:
Yellow fever
Dengue fever
Japanese encephalitis
Morphology
 Nucleic acid: ss+RNA
Classification related to pestiviruses
and flaviviruses
In vivo replication: liver and
lymphocytes
Genome size : 9.6 kb
morphology
1-structural proteins
.cover protein E1
.cover protein E2
.one peptide in E2
2-non structural proteins
NS2
NS3
NS4A
NS4B
NS5A
NS5B
Builds and converts proteins and sugars
Stores vitamins, sugars, fats and other nutrients
Releases chemicals and nutrients into the body
when needed
Egypt: 10- 30%
Japan Taiwan Italy: in up to 41 years old persons
45%
Africa, America, Europe, Eastern south Asia: under
2,5%
South era of Aram ocean countries: 2,5- 4,9%
Middle east: 1-12%
Epidemiology
Genotype 1: 40-80%
Genotype 2: The most prevalence after genotype 1
Genotype 3: India Pakistan Scotland Australia
Genotype 4: middle east, Africa, Egypt(90%)
Genotype 5: south Africa
Genotype 6: hong-kong
The most subtypes of America: (1a , 1b)
Iran: (1b, 47%) (3a, 36%) (1a, 8%) (4, 7%)
1a, 1b
2a, 2b,
3a
1a, 1b
2a, 2b, 2c,
3a
4
5a
1b
1b,
6
1b,
3a
1b,
3a
3b
4
Fang et al. Clin Liver Dis. 1997.
1a, 1b,
2b, 3a
2a
HCV Infection:
Worldwide Genotype Distribution
What About Alcohol?
Drinker Without Hepatitis C
Drinker With Hepatitis C
Hepatitis C Non-Drinker
Chance Of Getting
Cirrhosis
Non-Drinker
Disease burden due to HCV is substantial
Kwong et al PLoS One 2012
Human papilloma virus
E. Coli
HIV/AIDS
Staphylococcus aureus
C. Dificile
Rhinovirus
Group B Strep
Group A Strep
Haemophilus influenza
Legionella
Chlamydia
Adenovirus
Gonorrhea
Health Adjusted Life Years (HALYs)
0 2000 4000 6000 8000 1000
Tuberculosis
Influenza
Hepatitis B virus
Hepatitis C virus
Respiratory syncytial virus
Parainfluenza virus
Years of Life Lost
Year-equivalents of reduced functioning
Streptococcal pneumonia
High Risk
How Do People Become
Infected With Hepatitis C?
• Blood products
– Blood transfusions before 1992
• Other blood products before 1987
– Current transfusions no longer a major risk factor
• Injection (IV) drug use – 60% of all new
infections
Lower Risk:
• Snorting cocaine or other drugs
• Occupational exposure
• Body piercing & acupuncture with
unsterilized needle
• Tattooing
Lower Risk:
• From pregnant mother to child
• Non-sexual household contacts (rare)
– Sharing razors and/or toothbrushes
• Sexual transmission
– Low risk in monogamous relationship
Hepatitis C is NOT
Spread By:
• Sneezing
• Coughing
• Food or water
• Sharing drinking
glasses or eating
utensils
• Handshakes
• Holding hands
• Hugging
• Kissing on the cheek
• Playing with children
• Donating blood
How Will You Know if You
Have Hepatitis C?
• Many people have no symptoms of the virus
• If you do have symptoms:
• The only way to know if you have hepatitis c
is to have a blood test
• Fatigue • Discomfort in the liver area
• Loss of appetite • Aching joints
• Trouble sleeping • Depression
How is Hepatitis C
Diagnosed?
• Blood testing
1. Hepatitis C antibody
test
2. Hepatitis C PCR
test to find virus in
blood
• Liver function tests
Testing
 Antibody test
 ‘Window period’ – 2 weeks up to 6 months, but on average 6 to 12 weeks.
Indicates a person has been exposed to the virus. Doesn’t determine if
infection is current or what genotype is present
 PCR tests
Qualitative – virus detected/not detected
Quantitative – viral load
Genotype
Diagnosis
Serologic ways:
1: ELISA (Enzyme-Linked ImmunoSorbant assay)
2: RIBA (Recombinant immunoblot assay)
3: HCVcAg (HCV Core Antigen)
Virologic ways
HCV RNA
RT-PCR tests for HCV RNA
1. Amplicor Hepatitis c Virus Test,Version 2.0
2. Cobas Amplicor Hepatitis C Virus Test,Version 2.0
PCR test:
1: RT-PCR
2: bDNA(Chain DNA Assay Branched)
Genotype tests
1- Trugene HCV SNC Genotyping
2- Line-Probe-Assay
and the others way:
1- liver biopsy
2- liver imaging
3- andoscopy
4-phibroscan and …
Why Should You Be Concerned
About Hepatitis C?
• Hepatitis C causes serious problems in some
patients
• Fibrosis
• Cirrhosis
• Advanced liver disease
• Hepatocellular carcinoma (liver cancer)
Response To Treatment
(Time)
1-RVR (Rapid Virologic Response)
2-EVR (EarlyVirologic Response)
3-ETR (End Of Treatment Virologic Response)
4-SVR (Sustained Virologic Response)
5-LTR (Long-Term Virologic Response)
DRUGS for Treatment
1: Interferon
2: Ribavirin
3: (PEG) Interferon
4: Protease Inhibitors:
1: Boceprevir 2: Telaprevir
1: Ribavirin + PEG Interferon + Protease Inhibitors = Genotype 1
2: Sofosbuvir = All genotypes treated
3: Sofosbuvir + Ribavirin = Geno 2 , 3 and Cirrhosis
4: sofo+ riba+ PEG IFN = geno 1,4, 5 ,6 and cirrhosis
How Can You Prevent the
Spread of Hepatitis C?
• Cover open wounds
• Tell people not to touch your blood
• Clean blood spills yourself or inform others to
use latex gloves
• Dispose of needles/materials properly
• Do not inject drugs
• Avoid sharing contaminated articles
– Razors, toothbrushes, or other personal care
items
• Inform healthcare professionals/others
• Do not donate blood, body organs, tissues or
semen
• Practice safe sex
Those With Hepatitis C Should
• Take care not to spread hepatitis C to others
• Be vaccinated for hepatitis A and hepatitis B
• Discuss treatment options with a
knowledgeable medical professional
HCV – Natural History
Acute HCV-100 patients
Resolved - 25 Chronic - 75
Stable – 45-55 Cirrhosis – 20-30
Stable – 15-25
Decompensation – 5-8
HCC – 1-3 per year
20 – 30 years
Accelerated by:
alcohol
HIV

More Related Content

What's hot

Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
drvktiwari
 
hepatitis B VIRUS
hepatitis B VIRUShepatitis B VIRUS
hepatitis B VIRUS
joydeep1886
 
Viral hepatitis A
Viral hepatitis AViral hepatitis A
Viral hepatitis A
DrRajalekshmy Arun
 
Viral hepatitis 2013
Viral hepatitis 2013Viral hepatitis 2013
Viral hepatitis 2013
Mario Mondelli
 
Chronic hepatitis
Chronic hepatitisChronic hepatitis
Chronic hepatitis
Naveen Kumar
 
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
Dr. Afzal Haq Asif
 
Case Studies: HBeAg Negative Chronic Hepatitis B
Case Studies: HBeAg Negative Chronic Hepatitis B Case Studies: HBeAg Negative Chronic Hepatitis B
Case Studies: HBeAg Negative Chronic Hepatitis B
Yeong Yeh Lee
 
Hepatitis ppt final
Hepatitis ppt finalHepatitis ppt final
Hepatitis ppt final
deepak deshkar
 
Hepatitis virus : BDS 2nd year
Hepatitis virus : BDS 2nd year Hepatitis virus : BDS 2nd year
Hepatitis virus : BDS 2nd year
Huma Javeria
 
Hepatitis c
Hepatitis c Hepatitis c
Hepatitis c
Dr. Armaan Singh
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
Angel Das
 
Hiv
HivHiv
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
Hajer Alhadary
 
Harvoni and Hepatitis C revised
Harvoni and Hepatitis C revisedHarvoni and Hepatitis C revised
Harvoni and Hepatitis C revised
Thomas Huang
 
Viral Hepatitis Viral Hepatitis
Viral Hepatitis 	 Viral HepatitisViral Hepatitis 	 Viral Hepatitis
Viral Hepatitis Viral Hepatitis
MedicineAndHealthCancer
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
Mohammed Mohammed
 
Hepatitis C - Recent advances
Hepatitis C - Recent advancesHepatitis C - Recent advances
Hepatitis C - Recent advances
Subhasish Deb
 
Viral hepatitis by Dr. John
Viral hepatitis by Dr. JohnViral hepatitis by Dr. John
Viral hepatitis by Dr. John
Dr. Rubz
 
Hepatitis viruses a & e
Hepatitis viruses a & eHepatitis viruses a & e
Hepatitis viruses a & e
Suprakash Das
 
Hepatitis a, e, b
Hepatitis a, e, bHepatitis a, e, b
Hepatitis a, e, b
BAU
 

What's hot (20)

Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
 
hepatitis B VIRUS
hepatitis B VIRUShepatitis B VIRUS
hepatitis B VIRUS
 
Viral hepatitis A
Viral hepatitis AViral hepatitis A
Viral hepatitis A
 
Viral hepatitis 2013
Viral hepatitis 2013Viral hepatitis 2013
Viral hepatitis 2013
 
Chronic hepatitis
Chronic hepatitisChronic hepatitis
Chronic hepatitis
 
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
Hepatitis c. diagnosis and treatment.assld guidelines.2016 .2017
 
Case Studies: HBeAg Negative Chronic Hepatitis B
Case Studies: HBeAg Negative Chronic Hepatitis B Case Studies: HBeAg Negative Chronic Hepatitis B
Case Studies: HBeAg Negative Chronic Hepatitis B
 
Hepatitis ppt final
Hepatitis ppt finalHepatitis ppt final
Hepatitis ppt final
 
Hepatitis virus : BDS 2nd year
Hepatitis virus : BDS 2nd year Hepatitis virus : BDS 2nd year
Hepatitis virus : BDS 2nd year
 
Hepatitis c
Hepatitis c Hepatitis c
Hepatitis c
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hiv
HivHiv
Hiv
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Harvoni and Hepatitis C revised
Harvoni and Hepatitis C revisedHarvoni and Hepatitis C revised
Harvoni and Hepatitis C revised
 
Viral Hepatitis Viral Hepatitis
Viral Hepatitis 	 Viral HepatitisViral Hepatitis 	 Viral Hepatitis
Viral Hepatitis Viral Hepatitis
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis C - Recent advances
Hepatitis C - Recent advancesHepatitis C - Recent advances
Hepatitis C - Recent advances
 
Viral hepatitis by Dr. John
Viral hepatitis by Dr. JohnViral hepatitis by Dr. John
Viral hepatitis by Dr. John
 
Hepatitis viruses a & e
Hepatitis viruses a & eHepatitis viruses a & e
Hepatitis viruses a & e
 
Hepatitis a, e, b
Hepatitis a, e, bHepatitis a, e, b
Hepatitis a, e, b
 

Similar to Hepatities C

2. hiv aids lecture ppt
2. hiv aids lecture ppt2. hiv aids lecture ppt
Hepatitis and its complications
Hepatitis and its complicationsHepatitis and its complications
Hepatitis and its complications
Ivan Luyimbazi
 
Hepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusionHepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusion
SUJAY BHOWMIK
 
HIV In Pregnancy
HIV In PregnancyHIV In Pregnancy
HIV In Pregnancy
PAEDIATRICSDEPT
 
Hepatitis mbbch-2015
Hepatitis mbbch-2015Hepatitis mbbch-2015
Hepatitis mbbch-2015
Derar Ismerat
 
HEPATITIS C PRESENTATION
HEPATITIS C PRESENTATIONHEPATITIS C PRESENTATION
HEPATITIS C PRESENTATION
TANER YEKE
 
Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
Ayan Santra
 
Importance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseasesImportance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseases
Central Govt, India
 
POWER_POINT_presentation_(Covid-19).pptx
POWER_POINT_presentation_(Covid-19).pptxPOWER_POINT_presentation_(Covid-19).pptx
POWER_POINT_presentation_(Covid-19).pptx
PriyankarDutta1
 
Hepatitis c
Hepatitis cHepatitis c
Hepatitis c
avatar73
 
HIV and AIDS-Diagnosis & Treatment
HIV and AIDS-Diagnosis & TreatmentHIV and AIDS-Diagnosis & Treatment
HIV and AIDS-Diagnosis & Treatment
SayeedUllah2
 
Hepatitis C presentation
Hepatitis C presentation Hepatitis C presentation
Hepatitis C presentation
Amr Eldakroury
 
Hepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptxHepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptx
MuhammadAfrazNuman
 
Hepatitis
Hepatitis Hepatitis
Hepatitis
Harindu Udapitiya
 
Chronic hepatits c guidelines for screening and treatment lisa glass
Chronic hepatits c guidelines for screening and treatment lisa glassChronic hepatits c guidelines for screening and treatment lisa glass
Chronic hepatits c guidelines for screening and treatment lisa glass
Syed Ali
 
Hiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.ParamananthamHiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.Paramanantham
PAEDIATRICSDEPT
 
Hepatitis c (hcv)
Hepatitis c (hcv)Hepatitis c (hcv)
Hepatitis c (hcv)
Yangtze university
 
Coinfezione HIV HCV
Coinfezione HIV HCVCoinfezione HIV HCV
Coinfezione HIV HCV
Maria Teresa Mughini
 
Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
Microbiology
 
what is Hepatitis
what is Hepatitiswhat is Hepatitis
what is Hepatitis
Microbiology
 

Similar to Hepatities C (20)

2. hiv aids lecture ppt
2. hiv aids lecture ppt2. hiv aids lecture ppt
2. hiv aids lecture ppt
 
Hepatitis and its complications
Hepatitis and its complicationsHepatitis and its complications
Hepatitis and its complications
 
Hepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusionHepatitis c virus in blood transfusion
Hepatitis c virus in blood transfusion
 
HIV In Pregnancy
HIV In PregnancyHIV In Pregnancy
HIV In Pregnancy
 
Hepatitis mbbch-2015
Hepatitis mbbch-2015Hepatitis mbbch-2015
Hepatitis mbbch-2015
 
HEPATITIS C PRESENTATION
HEPATITIS C PRESENTATIONHEPATITIS C PRESENTATION
HEPATITIS C PRESENTATION
 
Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
 
Importance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseasesImportance of real time pcr in diagnosis of infectious diseases
Importance of real time pcr in diagnosis of infectious diseases
 
POWER_POINT_presentation_(Covid-19).pptx
POWER_POINT_presentation_(Covid-19).pptxPOWER_POINT_presentation_(Covid-19).pptx
POWER_POINT_presentation_(Covid-19).pptx
 
Hepatitis c
Hepatitis cHepatitis c
Hepatitis c
 
HIV and AIDS-Diagnosis & Treatment
HIV and AIDS-Diagnosis & TreatmentHIV and AIDS-Diagnosis & Treatment
HIV and AIDS-Diagnosis & Treatment
 
Hepatitis C presentation
Hepatitis C presentation Hepatitis C presentation
Hepatitis C presentation
 
Hepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptxHepatitisfull presenta and full all .pptx
Hepatitisfull presenta and full all .pptx
 
Hepatitis
Hepatitis Hepatitis
Hepatitis
 
Chronic hepatits c guidelines for screening and treatment lisa glass
Chronic hepatits c guidelines for screening and treatment lisa glassChronic hepatits c guidelines for screening and treatment lisa glass
Chronic hepatits c guidelines for screening and treatment lisa glass
 
Hiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.ParamananthamHiv in pregnancy by DR.Paramanantham
Hiv in pregnancy by DR.Paramanantham
 
Hepatitis c (hcv)
Hepatitis c (hcv)Hepatitis c (hcv)
Hepatitis c (hcv)
 
Coinfezione HIV HCV
Coinfezione HIV HCVCoinfezione HIV HCV
Coinfezione HIV HCV
 
Hepatitis C
Hepatitis CHepatitis C
Hepatitis C
 
what is Hepatitis
what is Hepatitiswhat is Hepatitis
what is Hepatitis
 

Recently uploaded

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
LaniyaNasrink
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Ayurveda ForAll
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 

Recently uploaded (20)

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptxREGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachIntegrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 

Hepatities C

  • 2.
  • 3. Hepatitis C • Identified in 1989 • Blood test became available in 1992 • Used to be known as “non-A, non-B” hepatitis • Spread through blood-to- blood contact • No vaccine available to prevent hepatitis C
  • 4. Flaviviridaea Hepaciviruses Pestiviruses: Classical swine Fever virus Bovine viral Diarhoea virus Flaviviruses: Yellow fever Dengue fever Japanese encephalitis
  • 5. Morphology  Nucleic acid: ss+RNA Classification related to pestiviruses and flaviviruses In vivo replication: liver and lymphocytes Genome size : 9.6 kb
  • 7. 1-structural proteins .cover protein E1 .cover protein E2 .one peptide in E2 2-non structural proteins NS2 NS3 NS4A NS4B NS5A NS5B
  • 8.
  • 9. Builds and converts proteins and sugars Stores vitamins, sugars, fats and other nutrients Releases chemicals and nutrients into the body when needed
  • 10.
  • 11. Egypt: 10- 30% Japan Taiwan Italy: in up to 41 years old persons 45% Africa, America, Europe, Eastern south Asia: under 2,5% South era of Aram ocean countries: 2,5- 4,9% Middle east: 1-12% Epidemiology
  • 12.
  • 13. Genotype 1: 40-80% Genotype 2: The most prevalence after genotype 1 Genotype 3: India Pakistan Scotland Australia Genotype 4: middle east, Africa, Egypt(90%) Genotype 5: south Africa Genotype 6: hong-kong The most subtypes of America: (1a , 1b) Iran: (1b, 47%) (3a, 36%) (1a, 8%) (4, 7%)
  • 14. 1a, 1b 2a, 2b, 3a 1a, 1b 2a, 2b, 2c, 3a 4 5a 1b 1b, 6 1b, 3a 1b, 3a 3b 4 Fang et al. Clin Liver Dis. 1997. 1a, 1b, 2b, 3a 2a HCV Infection: Worldwide Genotype Distribution
  • 15.
  • 16. What About Alcohol? Drinker Without Hepatitis C Drinker With Hepatitis C Hepatitis C Non-Drinker Chance Of Getting Cirrhosis Non-Drinker
  • 17. Disease burden due to HCV is substantial Kwong et al PLoS One 2012 Human papilloma virus E. Coli HIV/AIDS Staphylococcus aureus C. Dificile Rhinovirus Group B Strep Group A Strep Haemophilus influenza Legionella Chlamydia Adenovirus Gonorrhea Health Adjusted Life Years (HALYs) 0 2000 4000 6000 8000 1000 Tuberculosis Influenza Hepatitis B virus Hepatitis C virus Respiratory syncytial virus Parainfluenza virus Years of Life Lost Year-equivalents of reduced functioning Streptococcal pneumonia
  • 18. High Risk How Do People Become Infected With Hepatitis C? • Blood products – Blood transfusions before 1992 • Other blood products before 1987 – Current transfusions no longer a major risk factor • Injection (IV) drug use – 60% of all new infections
  • 19. Lower Risk: • Snorting cocaine or other drugs • Occupational exposure • Body piercing & acupuncture with unsterilized needle • Tattooing
  • 20. Lower Risk: • From pregnant mother to child • Non-sexual household contacts (rare) – Sharing razors and/or toothbrushes • Sexual transmission – Low risk in monogamous relationship
  • 21. Hepatitis C is NOT Spread By: • Sneezing • Coughing • Food or water • Sharing drinking glasses or eating utensils • Handshakes • Holding hands • Hugging • Kissing on the cheek • Playing with children • Donating blood
  • 22. How Will You Know if You Have Hepatitis C? • Many people have no symptoms of the virus • If you do have symptoms: • The only way to know if you have hepatitis c is to have a blood test • Fatigue • Discomfort in the liver area • Loss of appetite • Aching joints • Trouble sleeping • Depression
  • 23. How is Hepatitis C Diagnosed? • Blood testing 1. Hepatitis C antibody test 2. Hepatitis C PCR test to find virus in blood • Liver function tests
  • 24. Testing  Antibody test  ‘Window period’ – 2 weeks up to 6 months, but on average 6 to 12 weeks. Indicates a person has been exposed to the virus. Doesn’t determine if infection is current or what genotype is present  PCR tests Qualitative – virus detected/not detected Quantitative – viral load Genotype
  • 25. Diagnosis Serologic ways: 1: ELISA (Enzyme-Linked ImmunoSorbant assay) 2: RIBA (Recombinant immunoblot assay) 3: HCVcAg (HCV Core Antigen)
  • 26. Virologic ways HCV RNA RT-PCR tests for HCV RNA 1. Amplicor Hepatitis c Virus Test,Version 2.0 2. Cobas Amplicor Hepatitis C Virus Test,Version 2.0 PCR test: 1: RT-PCR 2: bDNA(Chain DNA Assay Branched)
  • 27. Genotype tests 1- Trugene HCV SNC Genotyping 2- Line-Probe-Assay and the others way: 1- liver biopsy 2- liver imaging 3- andoscopy 4-phibroscan and …
  • 28. Why Should You Be Concerned About Hepatitis C? • Hepatitis C causes serious problems in some patients • Fibrosis • Cirrhosis • Advanced liver disease • Hepatocellular carcinoma (liver cancer)
  • 29.
  • 30. Response To Treatment (Time) 1-RVR (Rapid Virologic Response) 2-EVR (EarlyVirologic Response) 3-ETR (End Of Treatment Virologic Response) 4-SVR (Sustained Virologic Response) 5-LTR (Long-Term Virologic Response)
  • 31. DRUGS for Treatment 1: Interferon 2: Ribavirin 3: (PEG) Interferon 4: Protease Inhibitors: 1: Boceprevir 2: Telaprevir 1: Ribavirin + PEG Interferon + Protease Inhibitors = Genotype 1 2: Sofosbuvir = All genotypes treated 3: Sofosbuvir + Ribavirin = Geno 2 , 3 and Cirrhosis 4: sofo+ riba+ PEG IFN = geno 1,4, 5 ,6 and cirrhosis
  • 32. How Can You Prevent the Spread of Hepatitis C? • Cover open wounds • Tell people not to touch your blood • Clean blood spills yourself or inform others to use latex gloves • Dispose of needles/materials properly • Do not inject drugs
  • 33. • Avoid sharing contaminated articles – Razors, toothbrushes, or other personal care items • Inform healthcare professionals/others • Do not donate blood, body organs, tissues or semen • Practice safe sex
  • 34. Those With Hepatitis C Should • Take care not to spread hepatitis C to others • Be vaccinated for hepatitis A and hepatitis B • Discuss treatment options with a knowledgeable medical professional
  • 35. HCV – Natural History Acute HCV-100 patients Resolved - 25 Chronic - 75 Stable – 45-55 Cirrhosis – 20-30 Stable – 15-25 Decompensation – 5-8 HCC – 1-3 per year 20 – 30 years Accelerated by: alcohol HIV